| Financial Year |
March 31 2023 |
| Monetary Funds |
555,522,790.04 |
| Held-for-trading Financial Assets |
1,097,119,181.94 |
| Notes Receivable |
18,209,761.92 |
| Accounts Receivable |
588,042,986.37 |
| Advances to Suppliers |
25,707,326.84 |
| Other Receivables |
21,654,314.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
554,067,276.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,006,280.27 |
| Total Current Assets |
2,985,581,047.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
89,204,838.66 |
| Investment Properties |
8,347,760.98 |
| Fixed Assetes |
163,315,767.14 |
| Under-construction Projects |
4,000,834.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,963,749.07 |
| R&D expenses |
-- |
| Goodwill |
17,852,301.66 |
| Long-Term Deferred and Prepaid Expenses |
4,180,382.22 |
| Deferred Income Tax Assets |
26,300,603.60 |
| Other Non-Current Assets |
13,759,005.02 |
| Sub-Total of Non-Current Assets |
463,354,315.01 |
| Total Assets |
3,448,935,362.47 |
| Short-Term Loans |
93,981.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,626,640.56 |
| Accounts Payable |
114,415,782.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,246,883.96 |
| Taxes Payable |
19,100,405.53 |
| Interest Payable |
4,458,369.00 |
| Dividend Payable |
380,000.00 |
| Other payables |
7,972,387.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
298,158,510.05 |
| Other Current Liabilities |
3,171,475.20 |
| Sub-Total of Current Liabilities |
754,680,204.13 |
| Long-term Loans |
636,645.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,069,168.51 |
| Total Liabilities |
758,749,372.64 |
| Paid-In Capital(Or Share Stock) |
630,112,103.00 |
| Capital Surplus |
471,739,405.29 |
| Surplus Reserve |
225,380,493.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,293,465,435.32 |
| Minority Stockholder's Interest |
6,140,088.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,684,045,901.45 |
| Owner's Equity（Stockholder's Equity） |
2,690,185,989.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,448,935,362.47 |
